|
Status |
Public on Nov 21, 2014 |
Title |
Targeting of Super-Enhancer-Associated Oncogenic Transcription in MYCN-driven tumor cells by CDK7 inhibition [ChIP-Seq] |
Organism |
Homo sapiens |
Experiment type |
Genome binding/occupancy profiling by high throughput sequencing
|
Summary |
ChIP-seq for Pol II, H3K27ac and H3K4me1 in neuroblastoma
|
|
|
Overall design |
ChIP-seq for Pol II, H3K27ac and H3K4me1 in neuroblastoma
|
|
|
Contributor(s) |
Chipumuro E, Marco E, Kwiatkowski N, Abraham B, George R |
Citation(s) |
25416950 |
|
Submission date |
Oct 27, 2014 |
Last update date |
May 15, 2019 |
Contact name |
Rani George |
E-mail(s) |
[email protected]
|
Phone |
617-632-5281
|
Organization name |
Dana Farber Cancer Institute
|
Department |
Pediatric Oncology
|
Lab |
Rani George Lab
|
Street address |
450 Brookline Ave
|
City |
Boston |
State/province |
MA |
ZIP/Postal code |
02115 |
Country |
USA |
|
|
Platforms (1) |
GPL9052 |
Illumina Genome Analyzer (Homo sapiens) |
|
Samples (18)
|
|
This SubSeries is part of SuperSeries: |
GSE62726 |
Targeting of Super-Enhancer-Associated Oncogenic Transcription in MYCN-driven tumor cells by CDK7 inhibition |
|
Relations |
BioProject |
PRJNA264969 |
SRA |
SRP049295 |